Mounjaro at depth
Educational reference only. Not medical advice. Verify dose, indications, and interactions with a licensed prescriber.
How Mounjaro works
Mounjaro (generic: tirzepatide injection) is a GLP-1 receptor agonist that modulates appetite and metabolism by mimicking the gut hormone glucagon-like peptide-1. Only FDA-approved formulations are available — no compounded equivalent is in widespread clinical use.
Who Mounjaro is for
Mounjaro is typically prescribed for patients with type 2 diabetes (FDA indication) or, off-label, adults with BMI ≥30 (or ≥27 with comorbidity) for weight management. Increasingly used in women managing PCOS-related insulin resistance. As with all prescription medications, suitability is determined by a licensed clinician based on individual medical history, current medications, and treatment goals.
Typical dose and cost
Average monthly cost runs around $1069, though actual pricing depends heavily on strength, pharmacy, and insurance coverage.
What to ask your prescriber
Before starting Mounjaro, ask your prescribing clinician about: your full medication and supplement list (for interaction screening), recent labs that are relevant to the medication's mechanism, monitoring cadence after starting, and what specific outcome they expect to see in the first 4–12 weeks.